Teva Branded Pharmaceutical Products R&d Llc

This study tested a new drug, modakafusp alfa, combined with daratumumab in 15 people with multiple myeloma that had returned or stopped responding to treatment. The main goals were to check safety and find the best dose. The study was terminated early, so results are limited.

This study tested an experimental drug called modakafusp alfa in people with multiple myeloma that had come back or stopped responding to other treatments. The goal was to find a safe dose and see if the drug could shrink tumors. The trial was stopped early, and results are not y…